FDA lifts hold on Juno's JCAR015

Juno Therapeutics Inc. (NASDAQ:JUNO) gained $6.96 (25%) to $34.75 in early after-hours trading Tuesday after it said FDA lifted a clinical hold on the company's

Read the full 256 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE